Effect of RSK4 on Biological Characteristics of Gastric Cancer

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Feb 26

PMID 32095082

Citations 6

Authors

Cong Hu

Jun Dai

Xu Lin

Ya Meng

Hui Liang

Affiliations

Soon will be listed here.

Abstract

Purpose: Gastric cancer is one of the most common cancers with high mortality. Emerging evidences show that ribosomal s6 kinase4 (RSK4) may be an anti-oncogene in several types of cancers, while its function in GC is still unclear. In the present study, we investigated the role of RSK4 in GC progression using MGC-803 and HGC-27 cell lines in vitro and in vivo.

Methods: The expression of RSK4 in gastric cancer cells was evaluated using RT-qPCR and Western blot analysis. We transfected cells with RSK4 siRNA to reduce the expression of RSK4 and then evaluated the effect of RSK4 on cellular function. MTT and cell cycle assays were used to study its effect on cell growth. Flow cytometry was used to evaluate cell apoptosis. Wound healing and Transwell assays were performed to investigate metastasis. Stable cell lines with or without RSK4 knockdown were constructed with lentivirus and tumor-bearing mice were used to investigate the effect of RSK4 on cancer progression.

Results: The results revealed that reduction of RSK4 expression inhibited cell apoptosis and promoted cell proliferation, migration, and invasion. Additionally, RSK4 knockdown promoted tumorigenesis in vivo.

Conclusion: Our study demonstrated that RSK4 serves as a tumor suppressor in GC.

Citing Articles

RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data.

Spirrison A, Lannigan D Expert Opin Ther Targets. 2024; 28(12):1047-1059.

PMID: 39632509 PMC: 11801519. DOI: 10.1080/14728222.2024.2433123.

Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.

Arechavaleta-Velasco F, Dominguez-Lopez P, Acosta-Jimenez E, Diaz-Cueto L Mol Biol Rep. 2023; 50(8):6863-6870.

PMID: 37402066 DOI: 10.1007/s11033-023-08609-9.

Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance.

Chen S, Seckl M, Lorentzen M, Pardo O Int J Mol Sci. 2022; 23(23).

PMID: 36498899 PMC: 9737342. DOI: 10.3390/ijms232314569.

Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4.

Hu C, Chen X, Lin X, Dai J, Yu J BMC Pharmacol Toxicol. 2022; 23(1):65.

PMID: 36031631 PMC: 9420250. DOI: 10.1186/s40360-022-00605-2.

FOXP2 regulates thyroid cancer cell proliferation and apoptosis via transcriptional activation of RPS6KA6.

Yang F, Xiao Z, Zhang S Exp Ther Med. 2022; 23(6):434.

PMID: 35607372 PMC: 9121208. DOI: 10.3892/etm.2022.11361.

References

Frodin M, Gammeltoft S . Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol. 1999; 151(1-2):65-77. DOI: 10.1016/s0303-7207(99)00061-1. View

Correa P . Gastric cancer: overview. Gastroenterol Clin North Am. 2013; 42(2):211-7. PMC: 3995345. DOI: 10.1016/j.gtc.2013.01.002. View

Cai J, Ma H, Huang F, Zhu D, Zhao L, Yang Y . Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol. 2014; 7(8):4959-70. PMC: 4152057. View

Lopez-Vicente L, Armengol G, Pons B, Coch L, Argelaguet E, Lleonart M . Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors. Clin Cancer Res. 2009; 15(14):4546-53. DOI: 10.1158/1078-0432.CCR-08-3159. View

Thakur A, Sun Y, Bollig A, Wu J, Biliran H, Banerjee S . Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res. 2008; 14(14):4427-36. PMC: 3771666. DOI: 10.1158/1078-0432.CCR-08-0458. View

Thakur A, Rahman K, Wu J, Bollig A, Biliran H, Lin X . Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Mol Cancer Res. 2007; 5(2):171-81. DOI: 10.1158/1541-7786.MCR-06-0071. View

Li Q, Jiang Y, Wei W, Ji Y, Gao H, Liu J . Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer. Med Oncol. 2013; 31(1):793. DOI: 10.1007/s12032-013-0793-3. View

Ye Q, Wang X, Jin M, Wang M, Hu Y, Yu S . Effect of RSK4 on biological characteristics of colorectal cancer. World J Surg Oncol. 2018; 16(1):240. PMC: 6303929. DOI: 10.1186/s12957-018-1474-7. View

Buck M, Poli V, Hunter T, Chojkier M . C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell. 2001; 8(4):807-16. DOI: 10.1016/s1097-2765(01)00374-4. View

10.

Mariette C, Balon J, Piessen G, Fabre S, Van Seuningen I, Triboulet J . Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003; 97(7):1616-23. DOI: 10.1002/cncr.11228. View

11.

Dummler B, Hauge C, Silber J, Yntema H, Kruse L, Kofoed B . Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem. 2005; 280(14):13304-14. DOI: 10.1074/jbc.M408194200. View

12.

Lara R, Seckl M, Pardo O . The p90 RSK family members: common functions and isoform specificity. Cancer Res. 2013; 73(17):5301-8. DOI: 10.1158/0008-5472.CAN-12-4448. View

13.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

14.

Sen G, Blau H . A brief history of RNAi: the silence of the genes. FASEB J. 2006; 20(9):1293-9. DOI: 10.1096/fj.06-6014rev. View

15.

Elbashir S, Lendeckel W, Tuschl T . RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001; 15(2):188-200. PMC: 312613. DOI: 10.1101/gad.862301. View

16.

Sun Y, Cao S, Yang M, Wu S, Wang Z, Lin X . Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4. Oncogene. 2012; 32(14):1794-810. PMC: 3427418. DOI: 10.1038/onc.2012.200. View

17.

Song Z, Wu Y, Yang J, Yang D, Fang X . Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017; 39(7):1010428317714626. DOI: 10.1177/1010428317714626. View

18.

Kang S, Elf S, Lythgoe K, Hitosugi T, Taunton J, Zhou W . p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. J Clin Invest. 2010; 120(4):1165-77. PMC: 2846050. DOI: 10.1172/JCI40582. View

19.

Zhu J, Li Q, Liu J, Wei W, Yang H, Tang W . RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells. Oncol Rep. 2015; 34(6):3156-62. DOI: 10.3892/or.2015.4291. View

20.

Fogarty S, Grahame Hardie D . C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest. J Biol Chem. 2008; 284(1):77-84. PMC: 2610510. DOI: 10.1074/jbc.M806152200. View